Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fatty acid desaturase 1 | 0.582 | 0.769 | 0.37 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 11 | 5.5E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 10 | 4.1E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 8 | 0.931 | 0.077 | 1.3E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 7 | 1.000 | 0.077 | 5.0E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 6 | 0.931 | 0.115 | 3.6E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 5 | 0.931 | 0.115 | 5.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 4 | 0.839 | 0.115 | 2.0E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 3 | 0.861 | 0.192 | 8.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 2 | 0.931 | 0.115 | 1.0E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protocadherin alpha 1 | 0.805 | 0.192 | 6.0E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
otoraplin | 0.805 | 0.154 | 4.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
phosphoribosyl transferase domain containing 1 | 0.805 | 0.385 | 2.4E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
coenzyme Q8A | 0.674 | 0.385 | 9.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
SPC25 component of NDC80 kinetochore complex | 0.729 | 0.346 | 2.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
kinase D interacting substrate 220 | 0.534 | 0.769 | 7.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
protocadherin alpha 12 | 2.4E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
protocadherin alpha 13 | 0.931 | 0.077 | 2.4E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
mitogen-activated protein kinase 4 | 0.821 | 0.231 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
EMAP like 6 | 0.931 | 0.115 | 4.1E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
lymphocyte antigen 75 | 0.670 | 0.538 | 7.4E-46 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
myosin light chain 2 | 0.601 | 0.615 | 2.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |